Survey shows many doctors less likely to recommend e-cigarettes for people seeking to quit smoking
MONDAY, April 18, 2022 (HealthDay News) — Many physicians incorrectly believe all tobacco products are equally harmful, according to a study published online April 15 in JAMA Network Open.
Cristine D. Delnevo, Ph.D., from Rutgers University in New Brunswick, New Jersey, and colleagues conducted an online survey to assess physician-patient communication regarding electronic cigarettes. The analysis included 2,058 board-certified physician respondents.
The researchers found that more than 60 percent of physicians believed all tobacco products to be equally harmful. Nearly seven in 10 physicians (69.8 percent) reported ever being asked about e-cigarettes by their patients and 21.7 percent reported ever recommending e-cigarettes to a patient. Physicians with greater odds of recommending e-cigarettes to patients included pulmonologists (adjusted odds ratio [aOR], 2.14), cardiologists (aOR, 2.04), and those implementing the U.S. Public Health Service Clinical Practice Guidelines (aOR, 1.77). Further, those who reported being asked about e-cigarettes had greater odds of recommending e-cigarettes (aOR, 16.60). In clinical scenarios, compared with a younger light smoker with no prior cessation treatments, physicians were more likely to recommend e-cigarettes for cessation to an older heavy smoker with multiple unsuccessful quit attempts (15.2 versus 49.3 percent).
“Results of this survey study suggest that physicians are recommending e-cigarettes for cessation or harm reduction under certain risk-based circumstances, such as treating patients with tobacco-related disease,” the authors write.
More Than 1 in 4 Americans Misrepresent Symptoms to Get Antibiotics
Hospital Outcomes Better When Patients Treated by Female Physicians
Financial Incentives Boost Tobacco Abstinence in Underserved Adults
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Maternal Night-Shift Work Tied to Later Neurodevelopmental Issues in Offspring
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy